Interleukin-18 Is a Potential Biomarker to Discriminate Active Adult-Onset Still’s Disease From COVID-19

Interleukin-18 Is a Potential Biomarker to Discriminate Active Adult-Onset Still’s Disease From COVID-19

BackgroundHyperinflammation with dysregulated production of galectins and cytokines may develop in COVID-19 or adult-onset Still’s disease (AOSD). Given the similar clinical features in both diseases, it is necessary to identify biomarkers that can differentiate COVID-19 from AOSD. However, the rela...

Full description

Bibliographic Details
Main Authors: Po-Ku Chen, Joung-Liang Lan, Po-Hao Huang, Jye-Lin Hsu, Ching-Kun Chang, Ni Tien, Hui-Ju Lin, Der-Yuan Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Immunology
Subjects:
galectins
cytokine profile
ferritin
COVID-19
adult-onset Still’s disease (AOSD)
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.719544/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.719544/full

Similar Items